Jinan Pharmaceutical and Medical Consumption Collection of "replacement with quantity" can be reduced throughout the year to reduce the burden of 1 billion yuan in medical treatment

The prices of drugs and medical consumables have made the masses still keep high in cure. The city's centralized procurement of drugs and medical consumables is used as an important livelihood. There are 6 batches of national and provincial 28 batch of 318 categories and 13 types of high -value medical consumables in our city in a timely manner. In addition, the city also organizes 1 batches of 13 kinds of drugs and 6 consumables in Jiji Medical Institutional Pharmaceutical Consumption. The selected products cover the clinical drugs and consumables of cardiovascular and cerebrovascular, diabetes, anti -tumor, joint replacement, etc. The average decrease of more than 50%, a maximum decrease of more than 90%. In 2022, in accordance with the agreed purchase volume of drugs and medical consumables in our market, the annual medical expenses can save more than 1 billion yuan, which effectively reduces the burden on the masses.

Reduce virtual high -priced people who are satisfied with satisfaction

Aunt Zhao, 68, is engaged in physical labor in the countryside all year round. She was diagnosed with "knee severe osteoarthritis" by the hospital. Knee joint replacement surgery was the only "knee" to restore normal walking. Due to the high price of artificial joint prosthesis before, Aunt Zhao was unable to undergo knee replacement surgery.

In April of this year, the national organized hip and knee joint high -value medical consumables were officially implemented in our city. Among them, the average price of hip joints dropped from 35,000 yuan to about 7,000 yuan, and the highest medium selection price was 9920 yuan, and the minimum medium selection price was 1788 yuan. The average price of knee joints dropped from 32,000 yuan to about 5,000 yuan. The lowest price is 2468 yuan. This means that artificial joints enter the "Thousand yuan era".

After learning about this good news, Aunt Zhao contacted Jinan Central Hospital for knee replacement surgery for the first time. After reimbursement from medical insurance, individuals only afforded more than 10,000 yuan. Aunt Zhao said excitedly: "Thank you for good medical insurance policies so that our ordinary people can enjoy the benefits of joint replacement surgery."

Similarly, there are coronary brackets with high usage rates in the treatment of heart disease. After centralized procurement, the average price dropped from 13,000 yuan to about 700 yuan. "Some people were previously limited by the economic situation, and they were boiled when they got sick. The price was reduced by collecting the price, which greatly reduced the burden on the masses to see a doctor." Medical expenses are nearly 300 million yuan, and artificial joints can save 288 million yuan per year.

Price reduction does not reduce quality and improves the pharmaceutical industry ecology

In addition to high -value medical consumables, chronic diseases and common medicines are also "hard bones".

Taking diabetic patients Akapo candy tablets (worship Tang Ping) as an example, after being selected for the collection of drugs, the price of each box drops from 61.29 yuan to 5.42 yuan. "The group of patients with chronic diseases in our city is relatively large, and chronic disease drugs need to be taken for a long time. Such a price reduction is really a gospel for them." The relevant person in charge of the Municipal Medical Insurance Bureau introduced that the commonly used blood lipid drugs Adinatin calcium tablets are also commonly used. From 3.7 yuan per piece to 0.12 yuan, the price decreased by 96.8%.

Some patients will have questions: the price drops to such low, and pharmaceutical companies need profit survival. Can the quality of the drug be guaranteed? Pharmaceuticals and medical consumables led by the medical insurance department are procurement models. It is a market scale advantage of batch procurement, exchanging prices, discussing bargaining, and squeezing the unreasonable profits of the intermediate link. For enterprises, on the one hand, sales scale has increased significantly, on the other hand, it reduces marketing costs such as sales promotion, effectively promotes marketing model adjustments and ecological purification of the pharmaceutical industry, and ultimately achieves the masses at relatively low prices to use high quality medicines and high -quality drugs and quality Consumption.

Make good use of the assessment and command stick to empower the innovative research and development of enterprises

In order to further enhance the enthusiasm of medical institutions and medical personnel to participate in the purchase of drug centralized band volume, in accordance with the relevant regulations of the superior, our city shall implement various aspects Take comprehensive assessment. The collection of medical insurance funds saved will be returned to medical institutions at a ratio of not higher than 50%for the performance of relevant personnel. For fixed -point medical institutions with unqualified assessment, they will not pay the collection of medical insurance for the collection of medical insurance. Since 2019, a total of 45.1921 million yuan in medical insurance funds has been allocated to 121 medical institutions, which has enhanced the enthusiasm of medical institutions to participate in collecting reforms.

"Bringing volume allows pharmaceutical companies to consume more funds and energy for drug sales." Qilu Pharmaceutical relevant person in charge said that before, the enterprise had a special sales team to run the hospital and the clinic. Overseas procurement effectively saves the cost and energy of the enterprise, and can invest more energy into innovative research and development.

At the same time, the corporate repayment has been guaranteed. Data show that the company will reduce the profit by nearly 1%for one month. The medical insurance fund is directly settled to the enterprise to collect the collection, and the return cycle is shortened from the average of more than 3 months to one month. Since November 2021, a total of 357 million yuan has been settled, and the settlement amount of local enterprises accounts for 93.84%of the summary amount. (Jinan Daily Reporter: Wang Xiaofei Correspondent: Zhang Hao Wang majesty)

- END -